16.91
price up icon0.03%   0.005
pre-market  プレマーケット:  16.78   -0.125   -0.74%
loading
前日終値:
$16.90
開ける:
$16.9
24時間の取引高:
4.35M
Relative Volume:
1.40
時価総額:
$4.03B
収益:
$426.45M
当期純損益:
$197.67M
株価収益率:
20.62
EPS:
0.82
ネットキャッシュフロー:
$110.10M
1週間 パフォーマンス:
-2.73%
1か月 パフォーマンス:
-15.09%
6か月 パフォーマンス:
-0.62%
1年 パフォーマンス:
+0.21%
1日の値動き範囲:
Value
$16.50
$17.02
1週間の範囲:
Value
$16.50
$17.41
52週間の値動き範囲:
Value
$14.62
$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name
名前
Adma Biologics Inc
Name
セクター
Healthcare (1151)
Name
電話
(201) 478-5552
Name
住所
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
職員
685
Name
Twitter
@AdmaBiologics
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
ADMA's Discussions on Twitter

ADMA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADMA
Adma Biologics Inc
16.91 4.10B 426.45M 197.67M 110.10M 0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-07-19 再開されました Raymond James Strong Buy
2022-10-13 開始されました Mizuho Buy
2021-11-11 アップグレード Raymond James Outperform → Strong Buy
2021-11-09 開始されました Cantor Fitzgerald Overweight
2019-06-04 開始されました Jefferies Buy
2019-04-15 繰り返されました H.C. Wainwright Buy
2019-02-07 再開されました H.C. Wainwright Buy
2017-12-11 繰り返されました Maxim Group Buy
2017-11-14 アップグレード Raymond James Mkt Perform → Outperform
2017-01-23 アップグレード Maxim Group Hold → Buy
2016-08-01 ダウングレード Maxim Group Buy → Hold
2016-07-25 繰り返されました Maxim Group Buy
2015-05-13 繰り返されました Maxim Group Buy
2014-12-08 開始されました Oppenheimer Outperform
2014-12-01 繰り返されました Maxim Group Buy
すべてを表示

Adma Biologics Inc (ADMA) 最新ニュース

pulisher
Sep 04, 2025

How to read the order book for ADMA Biologics Inc.July 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Automated trading signals detected on ADMA Biologics Inc.Product Launch & Safe Entry Zone Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is ADMA Biologics Inc. stock heavily shorted2025 Bull vs Bear & High Accuracy Investment Signals - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

ADMA Biologics Inc. stock volume spike explainedPrice Action & Growth Focused Investment Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What is ADMA Biologics Inc. s P E ratio telling usPortfolio Performance Summary & Smart Swing Trading Alerts - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Does ADMA Biologics Inc. qualify in momentum factor screeningWeekly Loss Report & Weekly Watchlist of Top Performers - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Real time scanner hits for ADMA Biologics Inc. explainedTrade Analysis Summary & Long-Term Capital Growth Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can a trend reversal in ADMA Biologics Inc. lead to recoveryWeekly Investment Summary & AI Optimized Trade Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Combining machine learning predictions for ADMA Biologics Inc.July 2025 Highlights & Weekly Breakout Opportunity Watchlist - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will ADMA Biologics Inc. continue its uptrendJuly 2025 Short Interest & Weekly Top Gainers Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Will ADMA Biologics Inc. stock go up soonJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for ADMA Biologics Inc.2025 Trading Volume Trends & Weekly High Return Stock Opportunities - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Ichimoku Cloud for ADMA Biologics Inc. technicals2025 Market Overview & Low Risk Growth Stock Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of ADMA Biologics Inc. stockRate Hike & High Yield Equity Trading Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Understanding ADMA Biologics Inc.’s price movement2025 Price Momentum & Growth Oriented Trade Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting ADMA Biologics Inc.’s strength2025 Retail Activity & Daily Profit Focused Stock Screening - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

ADMA Biologics: Boosting Earnings with Higher Plasma Yield and Diversified Product Mix - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

ADMA Biologics: Strong Product Mix, Growing Margins & Compelling Upside (NASDAQ:ADMA) - Seeking Alpha

Sep 03, 2025
pulisher
Sep 03, 2025

Is ADMA Biologics Inc. reversing from oversold territoryEarnings Overview Report & Weekly Watchlist of Top Performers - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can you recover from losses in ADMA Biologics Inc.Exit Point & Intraday High Probability Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of ADMA Biologics Inc. trendsWeekly Investment Report & Community Verified Swing Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is ADMA Biologics Inc. stock poised for growthPortfolio Value Report & Safe Swing Trade Setups - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Technical analysis overview for ADMA Biologics Inc. stockQuarterly Profit Review & Long Hold Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

ADMA Biologics Inc. stock chart pattern explainedJuly 2025 Earnings & Daily Market Momentum Tracking - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

ADMA Biologics Inc. stock outlook for YEARTrade Volume Report & Daily Oversold Stock Bounce Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is ADMA Biologics Inc. forming a double bottomMarket Risk Report & Fast Gain Swing Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Using economic indicators to assess ADMA Biologics Inc. potential2025 Market Trends & Weekly Market Pulse Updates - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How moving averages guide ADMA Biologics Inc. tradingShare Buyback & Stock Portfolio Risk Management - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Analyst Upgrade: What are ADMA Biologics Inc.’s technical support levels - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Candlestick signals on ADMA Biologics Inc. stock todayProfit Target & Daily Oversold Stock Bounce Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tools to monitor ADMA Biologics Inc. recovery probabilityDollar Strength & Risk Managed Investment Strategies - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Historical volatility pattern of ADMA Biologics Inc. visualizedQuarterly Market Summary & Verified Momentum Stock Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

ADMA Biologics Inc. stock daily chart insightsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What is the dividend yield of ADMA Biologics Inc.Stock Surge & Accurate Intraday Trade Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Real time breakdown of ADMA Biologics Inc. stock performance2025 Valuation Update & AI Based Buy and Sell Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 04:27:24 - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Backtesting results for ADMA Biologics Inc. trading strategiesTrade Volume Summary & Accurate Trade Setup Notifications - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Risk vs reward if holding onto ADMA Biologics Inc.Weekly Trade Report & Fast Gaining Stock Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ranking ADMA Biologics Inc. among high performing stocks via toolsLayoff News & Smart Allocation Stock Reports - Newser

Aug 31, 2025

Adma Biologics Inc (ADMA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Adma Biologics Inc (ADMA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Grossman Adam S
President and CEO
Aug 15 '25
Sale
16.88
21,000
354,480
2,031,850
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
Jul 30 '25
Option Exercise
8.98
2,500
22,450
489,898
Grossman Adam S
President and CEO
Jul 15 '25
Option Exercise
5.40
15,000
81,000
2,058,850
Grossman Adam S
President and CEO
Jul 15 '25
Sale
18.66
21,000
391,860
2,037,850
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
大文字化:     |  ボリューム (24 時間):